Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy

Drug delivery and triggered release in tumor cells would realize the ultimate goal of precise cancer treatment. An APE1 triggered DNA nanoprism was designed, aiming at the applications of both drug delivery and precise triggered drug release in cancer cell. We demonstrate that the AP-Prism was succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Meng, Li, Na, Liu, Fei, Zeng, Nan, Yu, Changyuan, Li, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704400/
https://www.ncbi.nlm.nih.gov/pubmed/35943146
http://dx.doi.org/10.1080/15384101.2022.2108567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704400/
https://www.ncbi.nlm.nih.gov/pubmed/35943146
http://dx.doi.org/10.1080/15384101.2022.2108567

Ejemplares similares